OEM/ODM Supplier candida mannan - Carbapenem-resistant OXA-23 Detection K-Set (Lateral Flow Assay) – Genobio


Product Detail

Product Tags

Related Video

Feedback (2)

That has a sound small business credit, great after-sales service and modern production facilities, we've earned an outstanding standing amid our buyers across the earth for immunochromatography analyzer, KPC CRE, nasal spray, Our goal is "blazing new ground, Passing Value", in the potential, we sincerely invite you to mature up with us and create a vivid foreseeable future jointly!
OEM/ODM Supplier candida mannan - Carbapenem-resistant OXA-23 Detection K-Set (Lateral Flow Assay) – Genobio Detail:

Product Introduction

The Carbapenem-resistant OXA-23 Detection K-Set (Lateral Flow Assay) is an immunochromatographic test system intended for the qualitative detection of OXA-23-type carbapenemase in bacterial colonies. The assay is a prescription-use laboratory assay which can aid in the diagnosis of OXA-23-type carbapenem resistant strains.

Carbapenem-resistant NDM Detection K-Set (Lateral Flow Assay) 1

Characteristics

Name

Carbapenem-resistant OXA-23 Detection K-Set (Lateral Flow Assay)

Method

Lateral Flow Assay

Sample type

Bacterial colonies

Specification

25 tests/kit

Detection time

10-15 min

Detection objects

Carbapenem-resistant Enterobacteriaceae (CRE)

Detection type

OXA-23

Stability

The K-Set is stable for 2 years at 2°C-30°C

Carbapenem-resistant OXA-23

Advantage

  • Rapid
    Obtain result within 15 min, 3 days earlier than traditional detection methods
  • SOXA-23le
    Easy to use, ordinary laboratory staff can operate without training
  • Accurate
    High sensitivity and specificity
    Low detection limit: 0.10 ng/mL
    Able to detect most of the common subtypes of OXA-23
  • Intuitive result
    There is no need for calculation, visual reading result
  • Economic
    Product can be transported and stored at room temperature, reducing costs

The importance of CRE test

CRE (Carbapenem-resistant Enterobacteriaceae) are a family of germs that are difficult to treat because they are highly resistant to antibiotics. CRE infections usually happen to patients in hospitals, nursing homes, and other healthcare settings. Patients whose care requires devices like ventilators (breathing machines), urinary (bladder) catheters, or intravenous (vein) catheters, and patients who are taking long courses of certain antibiotics are most at risk for CRE infections.

Some CRE bacteria have become resistant to most available antibiotics. Infections with these germs are very difficult to treat, and can be deadly—one report cites they can contribute to death in up to 50% of patients who become infected.

To prevent the further spread of CRE, healthcare provides should

  • Stay aware of CRE infection rates. Ask if a patient has received medical care somewhere else, including another country.
  • Place patients that have been infected with CRE on Contact Precautions. Isolation is necessary.
  • Perform hand hygiene – use alcohol-based hand rub or wash hand with soap and water before and after contact with patient or their environment
  • Alert the receiving facility when you transfer a CRE patient, and find out when a patient with CRE transfers into your facility
  • Make sure labs immediately alert clinical and infection prevention staff when CRE are identified
  • Prescribe and use antibiotics wisely
  • Discontinue devices like urinary catheters immediately when no longer necessary

……
Rapidly identifying patients with CRE and isolating them from other ICU patients when appropriate, using antibiotics reasonably, and reducing invasive device use are important in preventing CRE transmission. CRE rapid test is a necessary prerequisite for the implementation of these methods, which makes it a crucial part of clinical CRE management

OXA-23-type carbapenemase

Carbapenemase refers to a type of β-lactamase that can at least significantly hydrolyze imipenem or meropenem, including A, B, D three types of enzymes classified by Ambler molecular structure. Class D, such as OXA-type carbapenemase, were frequently detected in Acinetobacteria. Recent years, there have been reports of hospitalization caused by OXA-23, i.e. Oxacillinase-23-like beta-lactamase. 80% of domestic carbapenem-resistant Acinetobacteria baumannii produce OXA-23-type carbapenemase, which makes the clinical treatment very difficult.

Operation

  • Add 5 drops of sample treatment solution
  • Dip bacterial colonies with a disposable inoculation loop
  • Insert the loop into the tube
  • Add 50 μL to the S well, wait for 10-15 minutes
  • Read the result

Carbapenem-resistant KPC Detection K-Set (Lateral Flow Assay) 2

Order Information

Model

Description

Product code

CPO23-01

25 tests/kit

CPO23-01


Product detail pictures:

OEM/ODM Supplier candida mannan - Carbapenem-resistant OXA-23 Detection K-Set (Lateral Flow Assay) – Genobio detail pictures


Related Product Guide:

Our products are greatly recognized and trustworthy by users and will fulfill continually shifting economic and social requires for OEM/ODM Supplier candida mannan - Carbapenem-resistant OXA-23 Detection K-Set (Lateral Flow Assay) – Genobio , The product will supply to all over the world, such as: Portugal, Belgium, Benin, We confirm to public, cooperation, win-win situation as our principle, adhere to the philosophy of make a living by quality, keep developing by honesty , sincerely hope to build up a good relationship with more and more customers and friends, to achieve a win-win situation and common prosperity.
  • Product variety is complete, good quality and inexpensive, the delivery is fast and transport is security, very good, we are happy to cooperate with a reputable company!
    5 Stars By Anastasia from Latvia - 2018.07.12 12:19
    Good quality, reasonable prices, rich variety and perfect after-sales service, it's nice!
    5 Stars By Sara from Juventus - 2018.02.12 14:52
    Write your message here and send it to us